湯玥,中國藥科大學副教授,碩士生導師,美國康奈爾大學訪問學者,藥物制劑研究所實驗室主任,,中國藥學會會員,中國顆粒學會會員,學術兼職包括International Journal of Pharmaceutics審稿人,《藥物生物技術》審稿專家,Journal of Clinical Trials&Patenting編輯,。
(1)Yue Tang,Jiabi Zhu, Dusheng Cheng,Xusong Zhang, Bo Zhou, Haiyan Shen. Effect of rhIL-2 in inhalant form on experimental respiratory tract infection with Klebsiella pneumoniae in mice. Acta Pharmaceutica Sinica, 2005,40(1):17-21.
(2)Yue Tang, Jiabi Zhu. Recombinant human interleukin-2 inhalation powders: Preparation and distribution characteristics in lung epithelial lining fluid and alveolar macrophage in rats. International Journal of Pharmaceutics, 2008,360:225-227.
(3)Yong Zhang, Jiabi Zhu, Yue Tang, Xijing Chen, Yan Yang. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery. Drug Development and Industrial Pharmacy, 2009,35(9):1059-1065.
(4)Dongfei Liu, Yifan Ge, Yue Tang, Yubing Yuan, Qing Zhang, Rui Li, Qunwei Xu. Solid lipid nanoparticles for transdermal delivery of diclofenac sodium: preparation, characterization and in vitro studies. Journal of Microencapsulation, 2010, 27(8): 726-734.
(5)Liqun Jiang, Yue Tang,* Hongjiu Zhang, Xifeng Lu, Xijing Chen and Jiabi Zhu、Importance of powder residence time for the aerosol delivery performance of a commercial dry powder inhaler aerolizer®, Journal of Aerosol Medicine and Pulmonary Drug Delivery,25(5): 265-279,2012
(6)Yue Tang*, Heyang Zhang, Xifeng Lu, Liqun Jiang, Xinyuan Xi, Jianping Liu, Jiabi Zhu. Development and evaluation of a dry powder formulation of liposome-encapsulated oseltamivir phosphate for inhalation.
Drug Delivery. 2013 Dec 4. [Epub ahead of print]